Among the different tumor entities, patients suffering from hepatocellular carcinoma and clear cell renal cell carcinoma had the most unfavorable outcome presenting with high PD-L2 expression in tumor tissues. This evidence concerns the gene PDCD1LG2 and hepatocellular carcinoma.